intentional thallium poisoning – verification and treatment

38
INTENTIONAL THALLIUM INTENTIONAL THALLIUM POISONING – VERIFICATION POISONING – VERIFICATION AND TREATMENT AND TREATMENT Pelclová D (1), Šenholdová Z (1), Lukáš E (1), Urban P (2), Lacina L Pelclová D (1), Šenholdová Z (1), Lukáš E (1), Urban P (2), Lacina L (3), Vlček K (1), Fenclová Z (1), Kitzlerová, E (4). (3), Vlček K (1), Fenclová Z (1), Kitzlerová, E (4). 1. Department of Occupational Medicine, Charles University, Prague 1. Department of Occupational Medicine, Charles University, Prague 2. National Institute of Public Health, Prague 2. National Institute of Public Health, Prague 3. Department of Dermatology; 3. Department of Dermatology; 4. Psychiatric Department, 4. Psychiatric Department, General University Hospital and First Medical faculty, General University Hospital and First Medical faculty, Charles University, Prague, Czech Republic Charles University, Prague, Czech Republic

Upload: tiana

Post on 14-Jan-2016

42 views

Category:

Documents


6 download

DESCRIPTION

INTENTIONAL THALLIUM POISONING – VERIFICATION AND TREATMENT. Pelclová D (1), Šenholdová Z (1), Lukáš E (1), Urban P (2), Lacina L (3), Vlček K (1), Fenclová Z (1), Kitzlerová, E (4). 1. Department of Occupational Medicine, Charles University, Prague - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

INTENTIONAL THALLIUM INTENTIONAL THALLIUM POISONING – VERIFICATION POISONING – VERIFICATION

AND TREATMENTAND TREATMENT

Pelclová D (1), Šenholdová Z (1), Lukáš E (1), Urban P (2), Lacina L (3), Vlček K (1), Pelclová D (1), Šenholdová Z (1), Lukáš E (1), Urban P (2), Lacina L (3), Vlček K (1), Fenclová Z (1), Kitzlerová, E (4).Fenclová Z (1), Kitzlerová, E (4).

1. Department of Occupational Medicine, Charles University, Prague 1. Department of Occupational Medicine, Charles University, Prague 2. National Institute of Public Health, Prague2. National Institute of Public Health, Prague

3. Department of Dermatology; 3. Department of Dermatology; 4. Psychiatric Department, 4. Psychiatric Department,

General University Hospital and First Medical faculty, General University Hospital and First Medical faculty, Charles University, Prague, Czech RepublicCharles University, Prague, Czech Republic

Page 2: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

THALLIUM

discovered in 1861 by Sir Williams Crooks 1862 by French chemist Claude-Auguste Lamy In Greek, thallos "green twig."

Using spectroscopy, the brightest lines in the spectrum of thallium are green

melting point 300º C (576º F) boiling point 1480º C (2,655º F)

elementary thallium non-toxic monovalent and threevalent salts very toxic LD about 900 mg

Page 3: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

THALLIUM

rather uncommon element world production 12 tons/year semiconductors,

photocells, optic glass, thermometers in medicine – Tl201radioactive tracer in heart

scintigraphy to detect myocardial ischaemia occurrence in minerals emissions 1500 tons/year granite, coal

Page 4: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

THALLIUM – IN THE PAST

Tl2SO4 has long been used as

rodenticide, insecticide Colorless and tasteless Tl acetate : treatment of veneric diseases, ringworm Depilatory agent Low therapeutic index Banned in the 1970ies in most countries

Page 5: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Toxicokinetics – inorganic salts

absorption by all ways, oral about 90% distribution to all tissues greatest concentration in the intestines, liver,

kidney, heart, brain and muscles excretion by faeces and urine, the proportion 2:1 enterohepatic circulation half-lives 1-30 days

Page 6: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Pathophysiology - 1 Similarities in charge and ionic radius between K+ and Tl+

ions), Tl substitutes for K:

1. blocks energy utilization by Na-K-ATPase channel = (active transport of monovalent ions - K+ across cell membrane)

Thallium disturbs maintaining of a resting potential across the membrane of active cells - Tl has 10-fold greater affinity.

Neuronal, cardiac and skeletal muscle cells 2. blocks energy production from glucose: ADP to ATP by

pyruvate kinase = K requiring enzyme - links anaerobic glycolysis to the Krebs cycle)

inhibition by binding with 50-fold affinity comparing to K.

Page 7: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Pathophysiology - 2

3. damages riboflavin, precursor of FAD forming an insoluble complex and intracellular sequestration of vit. B6

decrease of riboflavin disrupts metabolism by reducing activity of Krebs cycle

4. binds to SH groups and interferes with formation of disulphide bonds in keratin - structural damage to hair, nails

5. causes activation or inhibition of other enzymes (ALA synthetase, B12 metabolism…)

Page 8: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

2 Case reports

2 patients, mother and daughter, living in the same household

Very probably intentional poisoning by one member of the family

Oral intake Chronic

Page 9: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Patient Amother

44years old PH: no serious disease OH: super-market manager 1. poisoning November 2004 sudden strong chest pain, following 3

days severe pain with paresthesias in both lower limbs Symptoms disappeared within 3 weeks, following 3 weeks

persisted mild paresthesias and discomfort in the lower limbs

Page 10: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

2. poisoning

In March 2005 she developed suddenly a strong muscular pain in the lower limbs. The gait was painful „as on a broken glass“.

within 5 days she became bald. In April – one month stayed at neurology dept. With

suspicion on LI syndrome and posttraumatic stress disorder (anxious, depressive, had work overload and home conflict environment)

EMG, evoked potentials, MRI normal In June improvement, returned to work

Page 11: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

3. poisoning

August 2005 Progressive pain in lower limbs with paresthesias Blurred vision – she could differentiate only dark

and light spots in the periphery of the visual field After 3 weeks her condition improved a little Mild pain in the feet and knees persisted several

weeks Vision difficulties persisted Eye fundus : n. opticus atrophy

Page 12: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

HospitalizationDept. Occupat. Medicine

Admitted on January 31,2006 5 months after last intoxication 1) attempt to prove the poisoning 2) attempt to improve vision damage – she still could not

read

EMG: mild motor and sensoric damage, EEG borderline

Visual evoked potentials: severe damage with visus BIOLOGICAL HALF-LIFE of thallium broad range of 1-30 days Hoffman RS. Toxicol Rev 2003

Page 13: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Patient B: Historydaughter

22years old woman PH: no serious disease OH: high school,1 year maternity leave FH: mother treated for symptoms of unknown etiology,

father probably psychopathic personality, no treatment, daughter 1 year old, healthy

Page 14: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

1 poisoning

In December 2005 suddenly strong pain in lower limbs,

maximum in the stockings distribution, ache in the skin of lower extremities

Anorexia 3rd week symptoms deteriorated, treated with analgesics

(tramadol) 4th week lost all body hair (except eyebrow and eyelashes) She developed blurred vision, weakness of lower limbs,

unable to walk Hospitalized at neurology dept.

Page 15: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Hospitalization at Neurology Dept.

Blood and urine sent to toxicology screening (drugs, metals incl. Cd, Pb, Hg, Se, Zn, Tl,)

5th week: vision damage with maximum in the central area, right and left eye

Shortly also speaking difficulties and feeling of heavy tongue Positive results for thallium in blood and urine

Page 16: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Hospitalization atDept. Occup. Medicine

Admitted on January 26, 2006 7th week of symptoms On admission: On a wheel chair, paraparesis, motor weakness Bald (only eyebrow and lashes left) Could distinguished fingers from 30 cm complained of

strong pain in lower limbs Altered mental status, depressive, anxious Slow speech, low voice

Page 17: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Antidote

Prussian blue - Fe4[Fe(CN)6]3 (ferric hexacyanoferrate), Radiogardase, Heyl CAS 14038-43-8 discovered 1704 by a Berlin color maker Diesbach since the 1960s used to treat Cs and Tl poisonings Binds thallium by ion exchange, adsorption and

mechanical trapping within the crystal structure

Page 18: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Specific treatment

Insoluble, low absorption from the GIT (?) stops enterohepatic circulation of thallium Increases elimination both to faeces and urine Advantage: rare side effects, bluish sweat and

tears Reduces half-life from 8 to 3 days First dose after arrival 6g /12 hours Continued with 12 g/day in 4 doses

Page 19: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Supportive therapy

10% mannitol as cathartic Charcoal (Carbosorb) 2x 25 g/day Analgesics Vit. B12, B6 Topical dermatological treatment supporting hair growth

Page 20: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Thallium concentration in urine µg/l in the daughter Total excretion 8.4 mg in 32 days, further Tl in faeces

Antidotal treatment 22 days

Page 21: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Toxicological analysis in daughter

Thallium found in all biological materials – blood, urine, faeces, hair

Page 22: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Examinations

Neurological (incl. needle EMG, VEP, BAEP, EEG, MRI of the brain)

Ophthalmological (visus, fundus, perimeter) Dermatological Further: ECG, psychiatric, blood biochemical analysis, urinalysis,

kidney functions

Page 23: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

January 20052nd month

Unable to walk Severe polyneuropathy Verified by needle EMG sensory, motoric and autonomic Symmetrical Low extremities only

Page 24: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

April 20065th month

Able to walk with a walker leg support. Severe motor polyneuropatie. Mild improvement,

esp. Sensitive and autonomic nerves. MRI of the brain: normal finding incl. optic nerves,

tracts, chiasma and visual cortex Atrophy of both optic nerves on the ocular fundus

Page 25: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

August 20069th month

Still severe motor polyneuropathy She could walk without support Unstable gait Pathology in EEG, VEP, BAEP Vision of fingers from 0.75 m

Page 26: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

EEG, BAEP VEP

Slightly abnormal entrance findings

Control: slow improvement

2nd month: no response due to severe vision damage

5th month: Low peak at right side, no response left side.

9th month: Bilaterally abnormal finding low reproducibility and low VEP, worse left side

Page 27: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

FURTHER FINDINGS

ECG – non-specific ST segment and T wave changes during a febrile state with tachycardia

Transthoracic echocardiography – diffuse hypokinesis of the left ventricle, markers normal

Psychiatric examination Neuropsychological testing not possible – visual

problems USG of the abdomen normal Kidney functions normal

Page 28: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Total alopeciadaughter

Reversible Highest value 36.1 μg/g (5th week) Sequential analysis of 1.5 cm hair segments = 6 months Thallium 5.61- 6.24 – 7.41 – 7.81 – 6.67 μg/g hair New hair 6th week of poisoning and 8th day of antidote

treatment– drop to 1.6 μg/g) Daniel J Am Acad Dermatol 2004

Page 29: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Trichological analysis of the acute hair loss of the daughter Normal hair

Light microscopy - The proximal end hair fibre tapered and distorted.  Rough surface of the proximal end Amorphous cuticular and cortical cells as a sign of the

pathological keratinisation. (Metter and Vock 1984)

Page 30: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Trichological analysis of the acute hair loss of the daughter

Under transmitted-light microscopy the cortex dark discolorisation and disorganized on the widened club-shaped end.

Gaseous inclusions under the phase contrast microscopy.

Page 31: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Trichological analysis of the new hair of the mother

Hair of the acute loss not available Recent hair – normal finding, smooth surface

of keratinocytes

Page 32: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Thallium in urine (μg/l) Optical Emission Spectrometer - Inductively Coupled Plasma (OES-ICP)

daughter mother normal range

Initial

measurement urine 580.00Jan.15

8.50Jan. 25

0.018-0.021

Page 33: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Thallium in urine (μg/l) voltammetry

daughter mother control subject

before antidote 580 neg. neg.

maximum after antidote/

12 h sample

urine 1170.0 21.0 4.0

end of treatment

12 h sample

urine 2.0 5.4 -

after 6 months urine neg. neg. -

Page 34: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

Thallium in blood and faecesOptical Emission Spectrometer - Inductively Coupled Plasma (OES-ICP)

μg/l daughter mother normal range

(OES-ICP)

First

measurement

blood 770.00Jan. 15

0.30Jan. 21

0.049-0.013

mg daughter mother Voltammetry

maximum with antidote

faeces 13 mg/250g 0.25 mg/40g ?

3 days after the end of treatment

faeces 0.1mg/100g 0.05 mg/70g neg.

Page 35: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

CONCLUSION - mother

Treatment with Prussian blue produced a higher excretion of thallium in urine

And a measurable amount in faeces In mother the clinical effect was negligible – 1¼ year after last poisoning: EMG: Residual mild axonal sensory neuropathy,

mild improvement after 6 months. Autonomic fibers without damage.

Opthalmologic examination: scotomas of upper and central parts of both visual fields

Visual evoked potentials: prologed latency, lower amplitude

Page 36: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

CONCLUSION - daughter

1 year after intoxication EMG examination - Severe damage in motor and

sensory fibers, autonomic normalized already Ophthalmologic examination – mild improvement right eye - scotomas in central and medium

periphery left eye – scotomas in central area

Page 37: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

SUMMARY Thallium typically causes damage of

peripheral nerves of lower extremities, vision and hair.

Combination of these symptoms suggests thallium poisoning

Late treatment has low effect Prognosis of hair loss is good Polyneuropathy improves within months till

years Vision damage has the worst prognosis

Page 38: INTENTIONAL THALLIUM POISONING – VERIFICATION  AND TREATMENT

THANK YOU

3rd victim – dog of the family